CENTRO DE SOLUÇÃO DO LESTE DA ÁFRICA
PAÍSES ACTIVOS ATUAIS
SOBRE NÓS
A ARC na África Oriental apoia os ministérios da saúde nesta região para fortalecer suas cadeias de abastecimento para melhorar a disponibilidade de medicamentos. A região também possui um Centro de Soluções que apóia as regiões no cumprimento da missão organizacional.
NOSSAS INICIATIVAS
Supporting Kenya's antiretroviral regimen transition
ARC performed an independent advisory role to shape the overall TLD transition project and brokered additional expert resources from Novo Nordisk and a local private sector consultant to support the initiative.
Leveraging private sector engagement to support medicine availability in Kenya
ARC has been working with the federation’s supply chain technical working group to engage the Ministry of Health in a collaborative platform where it can draw on insights and capabilities from the private sector.
Strengthening visibility across the public health supply chain in Kenya
ARC created dashboards that allow the Ministry of Health to easily monitor healthcare product inventory levels of down to the facility level.
Supporting the development of strategic components of supply chain strategy in Kenya
ARC and Johnson & Johnson collaborated to support the costing and implementation plan activities to inform the annual and multi-year operational budgets for Kenya’s health products and technologies supply chain.
Prestação de serviços diferenciados em Uganda (DSD)
A entrega de serviços diferenciados (DDS) é a estratégia e as intervenções da cadeia de suprimentos que apoiam a prestação de serviços e cuidados diferenciados. A ARC apoiará o Programa de Controle da AIDS do Ministério da Saúde para continuar a desenvolver e transformar a estratégia e o modelo de DDS de Uganda. A ARC prevê uma parceria plurianual ao longo de várias fases, com o foco da fase 1 sendo desenvolver e otimizar o modelo de DDS desejado para Uganda.
TLD Transition
Kenya has around 1.1 million people on ART and is embarking on a similar transition. As in South Africa, there are context-specific transition challenges. For example, there are multiple existing regimens and risks of expiry and wastages of stock due to poor visibility of stock levels and consumption at lower levels of healthcare. ARC will support NASCOP in refining the current Kenyan supply chain plan for transitioning from Tenofovir /Lamivudine/ Efavirenz to TLD in a way that addresses these challenges, as well as systematically identifying the lessons learned.